Arcotatug
Based on 1 Customer Validation
Arcotatug (IBI-343 antibody) is a CLDN18.2 targeting humanized monoclonal antibody. Arcotatug can be used for synthesis of ADCs.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 98%
- No. CAS: 3031170-61-0
- Peso molecular:145.647 kDa
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Human IgG1 kappa
Human
|
CLDN18.2 |
Arcotatug can be used to synthesize ADC Arcotatug tavatecan (IBI343), which shows anticancer activity in gastric or gastroesophageal junction adenocarcinoma[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa
ELISA, FACS, Functional assay
Chemical Information
-
No. CAS 3031170-61-0
-
Appearance Liquid
-
Peso molecular 145.647 kDa
-
Color Colorless to light yellow
-
SMILES
N/A
-
Synonyms
IBI-343 antibody; HB37A6; TAK-921 Antibody
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Arcotatug
- 3031170-61-0
- IBI-343 antibody
- HB37A6
- TAK-921 Antibody
- ADC Antibodies
- Claudin
- antibody-dependent cellular cytotoxicity
- complement-dependent cytotoxicity
- CLDN18.2
- IgG1 Fc silencing
- pancreatic ductal adenocarcinoma
- topoisomerase I
- gastric adenocarcinoma
- gastroesophageal junction adenocarcinoma
- biliary tract cancer
- Inhibitor
- inhibitor
- inhibit